ERNAW
Ernexa Therapeutics Inc. Warrants
NASDAQ · Financial Services · Asset Management · US
$0.04
−8.13%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -1.28x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 0.89x
Liquidity & coverage
- Current ratio
- 2.89x
- Quick ratio
- 2.89x
- Cash ratio
- 2.65x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $6.5M
Cash & dividend
- FCF / debt
- -18.65x
- Cash flow / debt
- -18.55x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026